Overview Topical Application to Relieve Gout: Efficacy Trial & Safety (TARGETS) Status: Recruiting Trial end date: 2021-04-01 Target enrollment: Participant gender: Summary This overall goal of this trial will be to demonstrate that DYV700 is safe and effective as a treatment for acute gout flares. Phase: Phase 2 Details Lead Sponsor: Dyve Biosciences, Inc.